KDM5B and neoplasm: Elevated levels of lysine demethylase 5B (KDM5B) have been found in a variety of human cancers, and it is considered to be a transcriptional suppressor associated with tumor growth, angiogenesis, invasion, metastasis, and tumor-related chemotherapy resistance (Zheng et al., 2019).